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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S148Purpose: Monocytes play a pivotal role in controlling tissue inﬂam-
mation and repair. They inﬁltrate the tissues and develop into twomain
subsets of macrophages in response to local signals: inﬂammatory (M1-
) and tissue-repair (M2-) macrophages (M4). Here we investigated
whether M1 and M24 differentially modulate chondrogenesis of mes-
enchymal stem/stromal cells (MSC).
Methods: Monocytes isolated from buffy-coats were cultured for 5 days
with GM-CSF or MCSF to induce respectively M1- or M24-polarization.
MSC were isolated from the bone marrow of a total of 9 patients and
expanded for two passages. MSC or skin ﬁbroblasts (as control cells) and
polarized macrophages were cultured in collagen scaffolds up to 3
weeks alone or after being mixed (at the ratio 1:1). In order to deter-
mine the reached cell number, selected constructs were generated by
combining carboxyﬂuorescein succinimidyl ester (CFSE) labeled MSC
with macrophages. To investigate the role of soluble factors in modu-
lating MSC differentiation, conditioned media harvested from M14 and
M24 were supplemented during the chondrogenic culture of MSC.
Resulting tissues and/or isolate cells were assessed histologically (gly-
cosaminoglycan, GAG), biochemically (GAG contents), cytoﬂuorimetri-
cally (percentage of cells expressing or not CD45, and CFSE) and by RT-
PCR (Sox9 and collagen-II)
Results: Coculture of MSC/M24 in scaffolds resulted in statistically
signiﬁcant 1.9-fold higher GAG content than what would be expected
(deﬁned as chondro-induction). Chondro-induction was lower (1.30.4)
and less reproducible when coculture was performed withM14 and did
not occur with skin ﬁbroblasts. GAG contents of constructs generated by
solely macrophages were undetectable. Histological analyses of con-
structs conﬁrmed the biochemical results. In the coculture there was no
modulation of the chondrogenic genes. As compared to monocultures,
in co-culture MSC and M24 numbers decreased less markedly (at day 7,
MSC were 84% and 42% of the initial number, M24 were 26% of the
initial number and undetectable, respectively for co-cultured and
monocultured cells).
Conclusions: We have demonstrated that coculture MSC/M42 results
in synergistic cartilage tissue formation, which is not mediated by
soluble factors alone. Further studies are envisioned to investigate
whether M42 modulate the survival of speciﬁc MSC sub-populations.
Finally, in vivo studies are necessary to assess the clinical relevance of
our ﬁndings in the context of cartilage repair.
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POSSIBLE CHONDROPROTECTIVE EFFECT OF CANAKINUMAB: AN IN
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Purpose: Canakinumab is a human IgGkmonoclonal antibody targeting
Interleukin (IL)-1b; its action involves the neutralization of IL-1b sig-
naling, resulting in suppression of inﬂammation in patients with
autoimmune disorders. IL-1b plays an important role also in the
destruction of cartilage and it is the most important cytokine in the
pathogenesis of osteoarthritis (OA). In response to IL-1b, chondrocytes
secrete other proinﬂammatory cytokines, neutral metalloproteinases
(MMPs), nitric oxide (NO); furthermore IL-1b inhibits chondrocytes
proliferation and induces apoptosis. The aim of our study was to eval-
uate the possible in vitro effect of canakinumab on cultures of human
OA chondrocytes cultivated in the presence or absence of tumor
necrosis factor (TNF)-a.
Methods: Human articular cartilage was obtained from the femoral
heads of 5 patients (range 63-71 years) with OA according to ACR cri-
teria undergoing surgery for total hip prostheses. The chondrocytes
were isolated from the articular cartilage using sequential enzymatic
digestion. The primary cultures so obtained were seeded in 6-well
plates until conﬂuence. Cells were then incubated with two concen-
trations (1mg/ml and 10mg/ml) of canakinumab alone or in combination
with TNF-a (10 ng/ml) for 48h. In these conditions we evaluated cell
viability, release of proteoglycans (PG) and NO in culture medium,
inducible nitric oxide synthase (iNOS) and MMP-1, 3, 13 expression, the
percentage of apoptosis and necrosis. After 24h we performed IL-1b
dosage (ELISA). Finally, we used a transmission electron microscope
(TEM) for morphological assessment. Data are expressed as the mean 
standard deviation of triplicate values for each experiment. Statisticalanalysis was performed using an analysis of variance followed by
Bonferroni multiple comparison tests.
Results: Canakinumab alone at the two concentrations studied hasn’t
cytotoxic effect, while TNF-a caused a signiﬁcant decrease of the per-
centage of viable cell (P < 0.001). Both concentrations of canakinumab
tested signiﬁcantly restored the cell viability in TNF-a stimulated
chondrocytes. As reported in Fig 1A, canakinumab alone at the two
concentrations studied didn’t modify signiﬁcantly IL-1b levels in the
culture medium, while TNF-a produced a signiﬁcant increase of IL-1b.
Both concentrations of canakinumab tested signiﬁcantly reduced IL-1b
production (Fig 1A). No signiﬁcant modiﬁcation of PG levels was
observed in the chondrocyte cultures treated with canakinumab alone.
The presence of TNF-a determined a signiﬁcant decrease (P < 0.001) in
PG levels and canakinumab signiﬁcantly increased the PG levels in cells
cultured with TNF-a in a dose-dependent manner. Incubation of
chondrocytes with canakinumab alone didn’t affect nitrite release. The
presence of TNF-a induced a signiﬁcant increase (P < 0.001) in NO
production. However, after co-incubation with TNF-a and canakinu-
mab, at different concentrations, the levels of NO decreased sig-
niﬁcantly (1mg/ml, P < 0.01; 10mg/ml, P < 0.01). The data of the NO
levels were conﬁrmed by the immunocytochemistry assay for iNOS.
TNF-a stimulated chondrocytes displayed a signiﬁcant increase of
MMP-1, 3, 13 gene expression; a signiﬁcant reduction was shownwhen
cells were co-treated with TNF-a and canakinumab (Fig 1B). Our
experiments conﬁrmed the pro-apoptotic effect of TNF-a and demon-
strated a protective effect of canakinumab at two concentrations
examined. The results concerning biochemical data were further con-
ﬁrmed by the morphological ﬁndings obtained by TEM.
Conclusions: It is generally accepted that IL-1b and TNF-a are the
pivotal cytokines involved in OA physiopathology. Hence, the neutral-
ization of these cytokines appears to be a logical development for OA
therapy. In the present study we showed, for the ﬁrst time, that cana-
kinumab counteracts the negative effect of TNF-a on OA chondrocyte
cultures, probably inhibiting IL-1b signaling.
Figure 1. A) IL-1b levels in the culture medium; B)MMP-1, 3, 13 gene
expression.
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BRAZILIN BLOCKS THE INDUCTION OF NFKB1/P50 IN HUMAN
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Purpose: Brazilin is one major constituent of Caesalpinia sappan and is
known to possess anti-bacterial, anti-oxidative, and anti-inﬂammatory
activities. Osteoarthritis (OA) creates a disequilibrium between the
catabolic and anabolic activities of chondrocytes in remodeling the
